158 related articles for article (PubMed ID: 38672507)
1. Radiolabelled FGF-2 for Imaging Activated Fibroblasts in the Tumor Micro-Environment.
Bentivoglio V; Galli F; Varani M; Ranieri D; Nayak P; D'Elia A; Soluri A; Massari R; Lauri C; Signore A
Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672507
[TBL] [Abstract][Full Text] [Related]
2. [Preparation of (99m)Tc-EDTA-MN and Its Bioimaging in Mouse].
Qi Y; Li G; Chi X; Du L; Huang K; Zhang H; Huang B
Zhongguo Fei Ai Za Zhi; 2015 Jul; 18(7):422-6. PubMed ID: 26182867
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a New
Farahani AM; Maleki F; Sadeghzadeh N; Abediankenari S; Abedi SM; Erfani M
Anticancer Agents Med Chem; 2020; 20(14):1695-1703. PubMed ID: 32560611
[TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis and Preclinical Assessment of
Trujillo-Benítez D; Luna-Gutiérrez M; Ferro-Flores G; Ocampo-García B; Santos-Cuevas C; Bravo-Villegas G; Morales-Ávila E; Cruz-Nova P; Díaz-Nieto L; García-Quiroz J; Azorín-Vega E; Rosato A; Meléndez-Alafort L
Molecules; 2022 Jan; 27(1):. PubMed ID: 35011496
[TBL] [Abstract][Full Text] [Related]
5. MicroSPECT/CT Imaging of Cell-Line and Patient-Derived EGFR-Positive Tumor Xenografts in Mice with Panitumumab Fab Modified with Hexahistidine Peptides To Enable Labeling with
Ku A; Chan C; Aghevlian S; Cai Z; Cescon D; Bratman SV; Ailles L; Hedley DW; Reilly RM
Mol Pharm; 2019 Aug; 16(8):3559-3568. PubMed ID: 31242384
[TBL] [Abstract][Full Text] [Related]
6. Imaging Tc-99m-labeled FGF-1 targeting in rats.
Zinn KR; Kelpke S; Chaudhuri TR; Sugg T; Mountz JM; Thompson JA
Nucl Med Biol; 2000 May; 27(4):407-14. PubMed ID: 10938477
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vitro/in vivo evaluation of novel mono- and trivalent technetium-99m labeled ghrelin peptide complexes as potential diagnostic radiopharmaceuticals.
Koźmiński P; Gniazdowska E
Nucl Med Biol; 2015 Jan; 42(1):28-37. PubMed ID: 25218025
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of a technetium-99m labeled cytotoxic bombesin peptide conjugate for targeting bombesin receptor-expressing tumors.
Okarvi SM; Al Jammaz I
Nucl Med Biol; 2010 Apr; 37(3):277-88. PubMed ID: 20346867
[TBL] [Abstract][Full Text] [Related]
9. Clinical translation of a PSMA inhibitor for
Ferro-Flores G; Luna-Gutiérrez M; Ocampo-García B; Santos-Cuevas C; Azorín-Vega E; Jiménez-Mancilla N; Orocio-Rodríguez E; Davanzo J; García-Pérez FO
Nucl Med Biol; 2017 May; 48():36-44. PubMed ID: 28193503
[TBL] [Abstract][Full Text] [Related]
10. PET imaging of oncogene overexpression using 64Cu-vasoactive intestinal peptide (VIP) analog: comparison with 99mTc-VIP analog.
Thakur ML; Aruva MR; Gariepy J; Acton P; Rattan S; Prasad S; Wickstrom E; Alavi A
J Nucl Med; 2004 Aug; 45(8):1381-9. PubMed ID: 15299065
[TBL] [Abstract][Full Text] [Related]
11. A novel dual-labeled small peptide as a multimodal imaging agent for targeting wild-type EGFR in tumors.
Kim MH; Kim SG; Kim DW
PLoS One; 2022; 17(2):e0263474. PubMed ID: 35120180
[TBL] [Abstract][Full Text] [Related]
12. Favorable biokinetic and tumor-targeting properties of 99mTc-labeled glucosamino RGD and effect of paclitaxel therapy.
Jung KH; Lee KH; Paik JY; Ko BH; Bae JS; Lee BC; Sung HJ; Kim DH; Choe YS; Chi DY
J Nucl Med; 2006 Dec; 47(12):2000-7. PubMed ID: 17138743
[TBL] [Abstract][Full Text] [Related]
13. [
Kaihani S; Sadeghzadeh N; Abediankenari S; Abedi SM
Ann Nucl Med; 2022 Nov; 36(11):976-985. PubMed ID: 36097232
[TBL] [Abstract][Full Text] [Related]
14. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
Ortiz-Arzate Z; Santos-Cuevas CL; Ocampo-García BE; Ferro-Flores G; García-Becerra R; Estrada G; Gómez-Argumosa E; Izquierdo-Sánchez V
Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877
[TBL] [Abstract][Full Text] [Related]
15. The Distribution and Imaging of
Fan G; Wan R; Zhang B; Deng S; Peng M; Xue W; Xu L; Qin X; Wu Y
Cancer Biother Radiopharm; 2018 Dec; 33(10):445-459. PubMed ID: 30133308
[No Abstract] [Full Text] [Related]
16. Pre-clinical evaluation of a new indirectly labeled ⁹⁹mTc-6-hydrazinopyridine-3-carboxylic acid (HYNIC)-depreotide with HYNIC as bifunctional chelator.
Yu F; Lü ML; Zhang XP; Fu D; Hou M; Cai HD; Li D; Wang J; Yuan XY; Lü ZW; Dong F
Chin Med J (Engl); 2012 Jul; 125(14):2538-42. PubMed ID: 22882936
[TBL] [Abstract][Full Text] [Related]
17. [99mTc]HYNIC-RGD for imaging integrin alphavbeta3 expression.
Decristoforo C; Faintuch-Linkowski B; Rey A; von Guggenberg E; Rupprich M; Hernandez-Gonzales I; Rodrigo T; Haubner R
Nucl Med Biol; 2006 Nov; 33(8):945-52. PubMed ID: 17127166
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of 99mTc-peptide-ZHER2:342 Affibody® molecule for in vivo molecular imaging.
Zhang JM; Zhao XM; Wang SJ; Ren XC; Wang N; Han JY; Jia LZ
Br J Radiol; 2014 Jan; 87(1033):20130484. PubMed ID: 24273251
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of novel Tc-99m labeled NGR-containing hexapeptides as tumor imaging agents.
Kim DW; Kim WH; Kim MH; Kim CG
J Labelled Comp Radiopharm; 2015 Feb; 58(2):30-5. PubMed ID: 25583160
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of Re/
Radford LL; Papagiannopoulou D; Gallazzi F; Berendzen A; Watkinson L; Carmack T; Lewis MR; Jurisson SS; Hennkens HM
Bioorg Med Chem; 2019 Feb; 27(3):492-501. PubMed ID: 30594453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
